The dysregulation of TRPC6 has been reported to be involved in the pathophysiology of several neurodegenerative diseases such as Alzheimer’s disease, cerebral ischemia, epilepsy, depression, and so on. The gene discussed is TRPC6; the disease is depressive symptom measurement.